Seres Therapeutics
MCRB
MCRB
80 hedge funds and large institutions have $237M invested in Seres Therapeutics in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 9 closing their positions.
Holders
80
Holders Change
-5
Holders Change %
-5.88%
% of All Funds
1.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
27
Reduced
31
Closed
9
Calls
$809K
Puts
$131K
Net Calls
+$678K
Net Calls Change
+$307K
Top Buyers
Top Sellers
| 1 |
AG
1
Artal Group
Luxembourg
|
$0 |
| 2 |
2
Capital World Investors
Los Angeles,
California
|
$6.08M |
| 3 |
3
Millennium Management
New York
|
$630K |
| 4 |
O
4
OrbiMed
New York
|
$699K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$3.09M |
